Triastek’s 3D printed drug T21 shows promise in treating ulcerative colitis
Chinese drug 3D printing firm Triastek has concluded its First-in-Human (FIH) study of its new 3D printing drug, dubbed T21. This drug is designed to treat moderate to severe ulcerative colitis (UC).